Quarterly ResultAug 11, 2026, 04:32 PM
Neuronetics Reports Q2 2026 Results; Raises Going Concern Doubt
AI Summary
Neuronetics, Inc. reported its second-quarter 2026 financial results, showing an increase in total revenue to $41.57 million and a reduced net loss of $(3.46) million compared to the prior year. However, the company disclosed substantial doubt about its ability to continue as a going concern, citing a projected failure to meet a minimum revenue covenant for March 31, 2027, which could lead to its credit facility being called. The company's cash and cash equivalents stood at $19.20 million, with net cash used in operating activities at $(10.43) million for the first six months of 2026.
Key Highlights
- Substantial doubt exists about Neuronetics' ability to continue as a going concern.
- Q2 2026 total revenue increased to $41.57 million from $38.11 million in Q2 2025.
- Q2 2026 net loss improved to $(3.46) million from $(9.84) million in Q2 2025.
- Q2 2026 basic and diluted net loss per share was $(0.05), compared to $(0.15) in Q2 2025.
- Cash and cash equivalents were $19.20 million as of June 30, 2026.
- Net cash used in operating activities was $(10.43) million for the six months ended June 30, 2026.
- Sold 6.05 million shares under ATM Program for $7.6 million net proceeds in Q2 2026.
- Long-term debt, net, stood at $61.52 million as of June 30, 2026.
Price Impact
More from STIM